Weinberg D S, Burnham D, Berlin J A
Division of Gastroenterology and Hepatology, Jefferson Medical College, Philadelphia, PA 19107, USA.
J Gen Intern Med. 1998 Sep;13(9):594-9. doi: 10.1046/j.1525-1497.1998.00181.x.
To determine the effect, if any, of histamine type 2 receptor antagonists (H2RAs) on serum alcohol levels under various conditions including type of H2RA receptor antagonist, alcohol dose, and fed status of the subject.
Meta-analysis of the published literature.
Studies were identified by MEDLINE (January 1982 through December 1997) using the key words H2 receptor antagonists and alcohol. Other studies were identified by reviewing bibliographies of retrieved articles and by discussion with colleagues.
Studies were selected if they involved the coadministration of H2RAs and alcohol in healthy, human volunteers. Studies that may have addressed this goal but were performed in another context, for instance the measurement of ulcer healing, were excluded.
Data were extracted on the design, number of participants, participant characteristics, type and dose of H2RA administered, serum alcohol levels (measured as Cmax) along with standard deviations, dose of alcohol received, and fed or fasted status of participants. Alcohol dose was arbitrarily divided into low dose (< or = 0.5 g/kg body weight) versus high dose (> 0.5 g/kg body weight). In addition, studies involving ranitidine and cimetidine were stratified by sample size into small (n < or = 10) versus not small (n > 10).
Twenty-four trials met selection criteria. Small elevations in Cmax were noted when cimetidine (2.71 mg/DL; 95% confidence internal [CI] 1.60, 3.83) or ranitidine (6.95 mg/DL; 95% CI 5.83, 8.08) were coadministered with alcohol. No such differences were noted for famotidine (0.28 mg/DL; 95% CI -1.24, 1.80) or nizatidine (2.33 mg/DL;, 95% CI -0.06, 4.72). The elevation detected with cimetidine and ranitidine was most pronounced in smaller studies (n < 10). Separate analyses investigating the effect of alcohol dose and fed or fasted status of participants revealed no clinically important differences.
Cimetidine and ranitidine, but not the other H2RAs, can cause small elevations of serum alcohol level when alcohol and drug are administered concurrently. Studies with larger numbers of participants were less likely to demonstrate this effect. Relative to accepted, legal definitions of intoxication, the effect of any H2RA on blood alcohol level is unlikely to be clinically relevant.
确定组胺2型受体拮抗剂(H2RAs)在包括H2RA受体拮抗剂类型、酒精剂量及受试者进食状态等各种条件下对血清酒精水平的影响(若有影响)。
已发表文献的荟萃分析。
通过MEDLINE(1982年1月至1997年12月)使用关键词“H2受体拮抗剂”和“酒精”检索研究。通过查阅检索文章的参考文献及与同事讨论确定其他研究。
若研究涉及在健康人类志愿者中联合使用H2RAs和酒精,则纳入研究。排除那些可能涉及此目标但在其他背景下进行的研究,例如溃疡愈合的测量。
提取关于设计、参与者数量、参与者特征、给予的H2RA类型和剂量、血清酒精水平(以Cmax测量)及其标准差、接受的酒精剂量以及参与者的进食或禁食状态的数据。酒精剂量被任意分为低剂量(≤0.5 g/kg体重)与高剂量(>0.5 g/kg体重)。此外,涉及雷尼替丁和西咪替丁的研究按样本量分层为小样本(n≤10)与非小样本(n>10)。
24项试验符合入选标准。当西咪替丁(2.71 mg/DL;95%置信区间[CI] 1.60,3.83)或雷尼替丁(6.95 mg/DL;95% CI 5.83,8.08)与酒精联合使用时,Cmax有小幅升高。法莫替丁(0.28 mg/DL;95% CI -1.24,1.80)或尼扎替丁(2.33 mg/DL;95% CI -0.06,4.72)未观察到此类差异。西咪替丁和雷尼替丁检测到的升高在较小规模研究(n<10)中最为明显。分别分析酒精剂量及参与者进食或禁食状态的影响,未发现具有临床意义的差异。
西咪替丁和雷尼替丁,而非其他H2RAs,在酒精与药物同时给药时可导致血清酒精水平小幅升高。参与者数量较多的研究不太可能显示出这种效应。相对于公认的、合法的中毒定义,任何H2RA对血液酒精水平的影响在临床上不太可能具有相关性。